Login / Signup

Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment.

Xueqing ChengPeina HuangHongyun LiuXiaojun BiYiping GaoRuirui LuYipeng GaoYani LiuYou-Bin Deng
Published in: Journal of diabetes investigation (2024)
This study suggests that 6-month treatment with empagliflozin improved LV, RV and LA functions in diabetes patients with normal ejection fraction.
Keyphrases
  • ejection fraction
  • aortic stenosis
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • heart failure
  • coronary artery disease
  • skeletal muscle
  • atrial fibrillation